BSF Enterprise PLC (BSFA) AI Stock Analysis

• Market Cap: £2.44M
• Dividend Yield: N/A
• Average Volume (3M): 374.14K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.54
• Revenue Growth: -64.18%
• EPS Growth: 12.05%
• Country: UK
• Employees: 15
• Sector: Healthcare
• Sector Strength: 45
• Industry: Asset Management
• EPS (TTM): >-0.01
• Shares Outstanding: 128,374,440
• 10 Day Avg. Volume: 343,597
• 30 Day Avg. Volume: 374,142
• PEG Ratio: -1.31
• Price to Book (P/B): 1.30
• Price to Sales (P/S): 71.49
• P/FCF Ratio: -2.58
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 56 Neutral
• Price Target: 3.00p ▲(57.89% Upside)

The stock's overall score is driven by strong technical momentum, despite weak financial performance and valuation concerns. The lack of profitability and negative cash flows are significant risks, but positive price trends provide some optimism.

Positive Factors

Strategic Partnerships

Strategic partnerships enhance BSFA's market presence and resource sharing, fostering innovation and competitive pricing, which are vital for long-term growth and profitability.

Strong Equity Position

A strong equity position provides BSF Enterprise PLC with a solid financial foundation, enabling it to withstand economic fluctuations and invest in growth opportunities.

Revenue Growth

BSF Enterprise PLC's revenue growth suggests a successful expansion of its market reach and product adoption, which is crucial for long-term sustainability and competitiveness in its industry.

Negative Factors

Declining Stockholders' Equity

Declining stockholders' equity, coupled with debt, may limit BSFA's financial flexibility and increase vulnerability to economic downturns, impacting long-term strategic initiatives.

Negative Cash Flow

Negative operating cash flow suggests that BSFA is not generating enough cash from its core activities to sustain operations, posing risks to its financial stability and ability to fund future growth.

Operational Losses

Despite revenue growth, ongoing operational losses indicate inefficiencies and challenges in achieving profitability, which could hinder long-term financial health and investment capacity.

BSF Enterprise PLC Business Overview & Revenue Model

Company Description

BSF Enterprise Plc does not have significant operations. It intends to acquire the companies or businesses within marketing and technology sectors. The company was incorporated in 2018 and is based in London, United Kingdom.

How the Company Makes Money

BSFA generates revenue through multiple streams, including the sale of manufactured products, distribution contracts, and service agreements. The company earns a significant portion of its income from direct sales of its core products to retailers and wholesalers. Additionally, BSFA has established strategic partnerships with other businesses, enabling it to expand its market reach and leverage shared resources for enhanced profitability. The company also invests in research and development to innovate and diversify its product offerings, which helps maintain competitive pricing and attract a broader customer base.

BSF Enterprise PLC Financial Statement Overview

Summary

BSF Enterprise PLC shows strong revenue growth but faces significant operational losses. The balance sheet is stable with a strong equity position, though declining, and cash flows are negative, indicating financial strain.

Income Statement

The company has shown a significant increase in revenue from previous years, indicating growth. However, the gross profit is negative, with substantial losses at the EBIT and net income levels, reflecting continued operational challenges and unprofitability.

Balance Sheet

The company maintains a strong equity position with a high equity ratio, indicating financial stability. However, the presence of debt and declining stockholders' equity over the years are potential risks.

Cash Flow

The cash flow statement reveals negative operating cash flow, which is concerning. Free cash flow remains negative, though capital expenditures are minimal. The company's operating activities are not generating sufficient cash to cover its losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	24.09K	57.82K	12.94K	0.00	0.00	0.00
Gross Profit	-142.04K	-26.64K	-86.55K	-160.50K	0.00	0.00
EBITDA	-1.64M	-1.68M	-1.46M	-905.76K	-58.22K	0.00
Net Income	-1.60M	-1.67M	-1.50M	-930.04K	-58.43K	-93.93K
Balance Sheet
Total Assets	3.19M	3.50M	5.26M	4.03M	401.45K	455.40K
Cash, Cash Equivalents and Short-Term Investments	338.96K	637.66K	2.32M	1.06M	359.87K	445.06K
Total Debt	37.07K	78.05K	156.93K	231.88K	0.00	0.00
Total Liabilities	301.34K	305.07K	401.63K	449.47K	36.63K	32.26K
Stockholders Equity	2.89M	3.19M	4.86M	3.58M	364.82K	423.14K
Cash Flow
Free Cash Flow	-1.43M	-1.60M	-1.44M	-677.86K	-85.19K	-107.14K
Operating Cash Flow	-1.42M	-1.59M	-1.38M	-667.24K	-85.19K	-107.14K
Investing Cash Flow	-6.09K	-12.02K	-64.85K	1.75K	0.00	0.00
Financing Cash Flow	393.57K	-78.88K	2.70M	1.37M	0.00	0.00

BSF Enterprise PLC Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BSFA, the sentiment is Negative. The current price of 1.9 is below the 20-day moving average (MA) of 2.02, below the 50-day MA of 2.32, and below the 200-day MA of 2.28, indicating a bearish trend. The MACD of -0.11 indicates Negative momentum. The RSI at 40.56 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BSFA.

BSF Enterprise PLC Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BSFA	56 Neutral	£2.44M	-1.30	-46.41%	―	-64.18%	12.05%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PRIM	48 Neutral	£4.81M	-7.86	-12.33%	―	―	―
CHP	44 Neutral	£4.94M	―	-95.95%	―	―	-100.00%
GUN	42 Neutral	£1.67M	-2.88	-21.15%	―	―	76.47%

BSF Enterprise PLC Corporate Events

BSF Enterprise Secures Shareholder Approval for Growth Initiatives

BSF Enterprise PLC announced the successful passing of all resolutions proposed during its General Meeting on December 17, 2025, with strong shareholder support for all listed items. This demonstrates robust investor confidence in the company’s direction and operations, solidifying its position as a leader in the development of sustainable tissue-engineered materials, with strategic implications for future growth in the cultivated meat, lab-grown leather, and biomedical sectors.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.

BSF Enterprise Expands Cultivated Meat Market with SeaWith Agreement

BSF Enterprise PLC’s subsidiary, 3D Bio-Tissues, has signed a commercial supply agreement with SeaWith, a South Korean cultivated-meat company, to provide its City-Mix® product. This agreement, valued at approximately £300K, is a significant milestone for BSF as it expands its reach into the cultivated-protein market. The collaboration aims to reduce production costs and enhance the scalability of SeaWith’s cultivated beef products, aligning with South Korea’s strategic initiatives to become a global hub for food-tech. The partnership is expected to boost BSF’s market position and accelerate the adoption of cultivated meat, benefiting from South Korea’s regulatory flexibility and growing demand for sustainable protein alternatives.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.

BSF Enterprise PLC Updates on Equity Fundraise and Capital Reorganisation

BSF Enterprise PLC has announced updates to its proposed Equity Fundraise and Capital Reorganisation, which are contingent on the approval of a Prospectus by the FCA by 28 February 2026. The company expects the record date for the Capital Reorganisation to be around 26 February 2026, with new ordinary shares to be credited on 27 February 2026. The Directors continue to recommend that shareholders vote in favor of the resolutions, and an announcement will follow the General Meeting to confirm the status of these resolutions.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.

BSF Enterprise PLC Launches Interactive Investor Website to Enhance Stakeholder Engagement

BSF Enterprise PLC, a leader in tissue-engineered materials, has launched a new interactive investor website to enhance communication with shareholders. This platform consolidates all company content, offering stakeholders access to regulatory announcements, reports, and educational materials, while also enabling direct interaction with the BSF team. The initiative aims to strengthen investor relations and provide deeper insights into the company’s technologies and commercial strategies.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.

BSF Enterprise PLC Announces £15 Million Equity Fundraise to Boost Growth

BSF Enterprise PLC, a leader in tissue-engineered materials, has announced a proposed £15 million equity fundraise to accelerate the commercialization of its core technologies, including lab-grown leather, corneal repair, and cell culture media supplements. The investment by Blackstone Mercantile Group marks a significant milestone in BSF’s growth strategy, enabling the company to expand its market presence, strengthen its intellectual property portfolio, and support talent acquisition. The funds will also facilitate strategic acquisitions and joint ventures, enhancing BSF’s technological footprint and commercial pipeline. The fundraise is expected to bolster the operations of BSF’s subsidiaries, LGL, Kerato, and 3D Bio-Tissues, allowing them to advance their respective projects and market offerings.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.

BSF Enterprise PLC Announces Transformative £15 Million Equity Fundraise

BSF Enterprise PLC has announced a conditional equity fundraise through a convertible loan note instrument and warrant instrument, aiming to raise up to £15 million in total. This initiative is expected to transform the company’s strategic development by accelerating the commercialization of its core technologies and supporting independent fundraising activities. The fundraise will also bolster marketing efforts, potential acquisitions, and liquidity, enhancing the company’s financial position and operational capabilities.

The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.